Literature DB >> 20374417

Scalp psoriasis.

Gottfried Wozel1, Eberhard Klein, Ulrich Mrowietz, Kristian Reich, Michael Sebastian, Volker Streit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20374417     DOI： 10.1111/j.1610-0387.2010.07412.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  8 in total

1.  [Use of salicylic acid oils on the scalp].

Authors:  S Melhorn
Journal:  Hautarzt       Date:  2017-03       Impact factor: 0.751

2.  Efficacy assessment of UVA1 and narrowband UVB for treatment of scalp psoriasis.

Authors:  Jing Zhou; Xuemei Yi; Ying Li; Yangfeng Ding
Journal:  Lasers Med Sci       Date:  2018-06-18       Impact factor: 3.161

3.  Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis.

Authors:  Marco Galluzzo; Marina Talamonti; Arnaldo Cioni; Virginia Maffei; Ruslana Gaeta Shumak; Lorenzo Tofani; Luca Bianchi; Elena Campione
Journal:  J Clin Med       Date:  2022-05-07       Impact factor: 4.964

Review 4.  [Psoriasis in special localizations].

Authors:  A Schmieder; W K Peitsch
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

5.  Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.

Authors:  Lawrence F Eichenfield; Cecilia Ganslandt; Merle Kurvits; Joel Schlessinger
Journal:  Pediatr Dermatol       Date:  2014-11-21       Impact factor: 1.588

6.  Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.

Authors:  M Gooderham; J-M Debarre; J Keddy-Grant; Z Xu; M Kurvits; M Goodfield
Journal:  Br J Dermatol       Date:  2014-10-22       Impact factor: 9.302

7.  Malassezia species infection of the synovium after total knee arthroplasty surgery.

Authors:  Hamed Ebrahimzadeh Leylabadlo; Elham Zeinalzadeh; Najibeh Asl Rahnemaii Akbari; Hossein Samadi Kafil
Journal:  GMS Hyg Infect Control       Date:  2016-09-27

8.  Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial.

Authors:  B E Elewski; C S Baker; J J Crowley; Y Poulin; M M Okun; B Calimlim; Z Geng; O Reyes Servin; P A Rich
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-09-04       Impact factor: 6.166
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.